Skip to main content
. 2016 Aug 15;33(12):2920–2929. doi: 10.1007/s11095-016-2014-1

Table I.

Study Design and Treatment Groups for the LDC Study

Treatment Groups
Group Route Dose
nmol BIL/kg
Total Dose
nmol/sheep
Matrix collected
LDC SC 3 120 Serum/Lymph
LDC IV 3 120 Serum/Lymph
non-LDC SC 3 120 Serum
non-LDC IV 3 120 Serum
non-LDC IV 1 40 Serum
non-LDC IV 0.5 20 Serum